Clinical trial
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
NCT07456865 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
- Lead sponsor
- MedtronicNeuro
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 17, 2026
- Completion date
- November 30, 2032
- Enrollment
- 256 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
urge urinary incontinence